Skip to main content

Table 3 Summary of Three Systematic Reviewsa

From: Cost-effectiveness of continuity of midwifery care for women with complex pregnancy: a structured review of the literature

Aim of Study

Sample / Setting

Design

Major Cost Findings

Health Outcomes

Strengths / Limitations

1. Sandall et al. (2016) Compare effects of midwife-led continuity models with other models for childbearing women and their infants

Primary outcomes antenatal, birth & immediate postpartum outcomes

Secondary outcomes birth intervention, morbidity, some aspects of resource use & cost United Kingdom √

Included: 15 RCTs 17 674 women (Canada, Ireland, Australia, UK) Excluded: 22 studies

Only 6 of the 15 RCTs measured cost of model; only 4 of the 6 RCTs that measured costs included “mixed risk” pregnant women/high risk pregnancy:

Kenny 1994 Rowley 1995 Homer 2001 Tracy 2013

Systematic review Cochrane Pregnancy & Childbirth Group Trials Register + reference lists of retrieved articles.

Selection criteria: published and unpublished trials, pregnant women randomly allocated to midwife-led continuity models of care or other models of care for pregnancy & birth

Cost trend reported narratively as RCT cost method varied, e.g. cost analysis; CEA; or not stated

Trend to cost saving effect in midwife-led continuity

Cost savings intrapartum care – all studies

Antenatal: varied

Postnatal: 1 study higher cost/ 1 study no difference

Primary 0utcome in midwife – led models

(RR) (CI)

regional analgesia (0.85, 0.78 – 0.92)

instrumental birth (0.90, 0.83 – 0.97)

pre-term <37 wk

(0.76, 0.64 – 0.91)

fetal loss <24 wk (0.84, 0.71 – 0.99)

spontaneous vaginal birth (1.05, 1.03 – 1.07)

No difference CS or intact perineum

Secondary 0utcome midwife – led models:

amniotomy; episiotomy; fetal loss <24 wks;

No labour analgesia; longer labour (MD) 0.50 hrs,

No difference for:

fetal loss >24 wks;

labour induction; A/N admission; A/N haemorrhage; augment labour; PPH; low birthweight; 5 min Apgar < 7; SCBU admission; initiate breastfeeding

Time horizon:

RCT (cost included)

1994 – 2013

Women receiving midwife care less likely to have epidural, episiotomies, instrumental birth.

Spontaneous vaginal birth rate increased.

CS rate no difference.

Women less likely to have pre-term birth, lower risk of losing babies < 24wks,

More likely to be cared for in labour by a known midwife.

No adverse effects compared with other models.

Conclusion: most women should be offered midwife-led continuity of care BUT

Evidence may not apply to women with serious pregnancy or health complications as these women were not specifically included in all studies / analysis for clinical effectiveness not stratified

Limited evidence CEA for women with complex pregnancy

Combined results: low and mixed risk pregnant women

4 studies used different economic evaluation methods -: narrative report as cost assessment inconsistent

Strong evidence cost improved in midwifery models for low risk with, reduced intervention + increased satisfaction.

Mixed risk studies - ‘interpret with caution’

2. Ryan et al. (2013) Analysis of evidence on cost – effectiveness of midwife-led care compared with consultant –led care in UK settings.

Estimate potential cost savings to accrue from expansion of midwife – led care in UK

Used Section 3 CE of Devane et al. 2010 SR

United Kingdom √

Economic synthesis of 3 RCTs evaluated against guidelines for economic review Drummond and Jefferson (1996) 5796 women

Hundley 1995 Young 1997 Begley 2009 Excluded:

Flint 1989 (sub-group costing 49 of 1001 women only)

Systematic review

12 electronic databases for cost midwife led models:

Cochrane Methodology Register

NICE methods + multiple 1-way sensitivity analysis for economic synthesis of costs used 3 RCTs applied to 8 scenarios

CE measure used Incremental Net Benefit (INB): expressed as Net Monetary Benefit (NMB) – £ value, and Net Health Benefit (NHB) – QALY, Quality adjusted life year gain

Mean cost saving £12.38 per woman midwife led (ML) care

Expansion of ML care to 50% of all eligible women in UK projected aggregate

£1.16 mil cost saving/yr

Sensitivity analysis: cost change per woman varied from saving £253.38 (37.5 QALYs gained per year) to cost increase £108.12 dependent on assumptions with correspondent aggregate annual savings £23.75 million, or aggregate annual cost increase £10.13 million

Time horizon:

RCT (cost included) 1995 – 2009

Three economic analyses used in synthesis of potential cost saving from increasing midwife-led services for eligible maternities.

Issues identified around generalizability of findings.

High rate of transfer from ML to medical-led care in studies demonstrates ‘risk’ assessment criteria unable to identify all women who will develop complications in pregnancy and labour

Rigorous health economic assessment

measures: INB, NMB,QALYs

Limited to UK system

Excluded RCTs from Australia and other countries where no comparison with consultant-led model

Mixed risk pregnancy profile; sub-group analysis show cost results consistent for groups as (RR) fetal loss and neonatal death overlap with 1.00

3. Devane, D. et al. (2010).

Section 3: assessed CE of midwife-led care compared with consultant –led care. Estimated potential cost savings of expanding midwife-led care in UK (pp. 33–45)

United Kingdom √

Based on 3 of 4 RCTs See 2. above

Hundley 1995

2844 women;

Young 1997 1299 women;

Begley 2009

1653 women

Systematic review see 2. above

Sensitivity analysis x 3 based on 8 scenario

SA 1: Systematically varying estimated cost savings

SA 2: Systematically varying RR for overall fetal loss & neonatal death using low risk and ‘mixed risk’ cases

SA 3: Systematically varying assumed uptake of ML service

As published in Ryan, Revill et al. 2013

Time horizon:

RCT (cost included)

1995 – 2009

Expanding midwife –led maternities show: Reduced rate of interventions in ML continuity of care, including:

<AN hospitalization

Reduced use of regional analgesia in birth, less episiotomy and instrumental delivery & greater numbers of women more likely to experience spontaneous vaginal birth BUT may not extrapolate to women with identified risk factors

Cochrane bias assessment tool used for trial internal validity

Not generalisable, small number of studies

CE varied with unit size, location and volume

  1. aArticles presented in reverse chronologic order; denotes a minimum PRISMA score of 20 based across a possible total of 27 check-list items